Processa Pharmaceuticals, Inc.(PCSA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | Guy Wendy Chief Administrative Officer | Purchase | +2,436 | +4.52%56,294 | $1.93 | $4,701 | View SEC filing | |
| 2026-07-01 | Lin Patrick Chief Business - Strategy Off | Purchase | +2,106 | +1.24%172,131 | $1.93 | $4,065 | View SEC filing | |
| 2026-07-01 | Ng George K Chief Executive Officer | Purchase | +3,057 | +1.10%281,556 | $1.93 | $5,900 | View SEC filing | |
| 2026-07-01 | SKIBSTED RUSSELL Chief Financial Officer | Purchase | +3,277 | +24.43%16,689 | $1.93 | $6,325 | View SEC filing | |
| 2026-07-01 | Young David Pres. Research & Development | Purchase | +2,531 | +0.52%488,724 | $1.93 | $4,885 | View SEC filing | |
| 2026-06-16 | Young David Pres. Research & Development | Purchase | +2,067 | +0.43%486,193 | $2.22 | $4,589 | View SEC filing | |
| 2026-06-16 | SKIBSTED RUSSELL Chief Financial Officer | Purchase | +2,654 | +24.67%13,412 | $2.22 | $5,892 | View SEC filing | |
| 2026-06-16 | Ng George K Chief Executive Officer | Purchase | +2,465 | +0.89%278,499 | $2.22 | $5,472 | View SEC filing | |
| 2026-06-16 | Lin Patrick Chief Business - Strategy Off | Purchase | +1,831 | +1.09%170,025 | $2.22 | $4,065 | View SEC filing | |
| 2026-06-16 | Guy Wendy Chief Administrative Officer | Purchase | +2,118 | +4.09%53,858 | $2.22 | $4,702 | View SEC filing | |
| 2026-06-01 | Young David Pres. Research & Development | Purchase | +1,786 | +0.37%484,126 | $2.57 | $4,590 | View SEC filing | |
| 2026-06-01 | SKIBSTED RUSSELL Chief Financial Officer | Purchase | +2,292 | +27.07%10,758 | $2.57 | $5,890 | View SEC filing | |
| 2026-06-01 | Ng George K Chief Executive Officer | Purchase | +2,129 | +0.78%276,034 | $2.57 | $5,472 | View SEC filing | |
| 2026-06-01 | Lin Patrick Chief Business - Strategy Off | Purchase | +1,582 | +0.95%168,194 | $2.57 | $4,066 | View SEC filing | |
| 2026-06-01 | Guy Wendy Chief Administrative Officer | Purchase | +1,829 | +3.66%51,740 | $2.57 | $4,701 | View SEC filing | |
| 2026-05-19 | Ng George K Chief Executive Officer | Purchase | +1,843 | +0.68%273,905 | $2.97 | $5,474 | View SEC filing | |
| 2026-05-19 | Young David Pres. Research & Development | Purchase | +1,545 | +0.32%482,340 | $2.97 | $4,589 | View SEC filing | |
| 2026-05-19 | Lin Patrick Chief Business - Strategy Off | Purchase | +1,369 | +0.83%166,612 | $2.97 | $4,066 | View SEC filing | |
| 2026-05-19 | Guy Wendy Chief Administrative Officer | Purchase | +1,583 | +3.28%49,911 | $2.97 | $4,702 | View SEC filing | |
| 2026-05-19 | SKIBSTED RUSSELL Chief Financial Officer | Purchase | +1,984 | +30.61%8,466 | $2.97 | $5,892 | View SEC filing | |
| 2026-05-19 | Ng George K Chief Executive Officer | Purchase | +1,843 | +0.69%270,028 | $2.97 | $5,474 | View SEC filing | |
| 2026-05-19 | Bigora Sian Chief Development Officer | Purchase | +1,971 | +3.28%62,072 | $2.71 | $5,341 | View SEC filing | |
| 2026-05-01 | Young David Pres. Research & Development | Purchase | +1,706 | +0.36%480,795 | $2.69 | $4,589 | View SEC filing | |
| 2026-05-01 | SKIBSTED RUSSELL Chief Financial Officer | Purchase | +2,190 | +50.84%6,498 | $2.69 | $5,891 | View SEC filing | |
| 2026-05-01 | Ng George K Chief Executive Officer | Purchase | +2,034 | +0.75%272,062 | $2.69 | $5,471 | View SEC filing |
1-25 of 79